Analyst firms · H.C. Wainwright · VSTM

H.C. Wainwright VSTM price target and rating history

Verastem Inc. (VSTM) · Health Care

H.C. Wainwright rates Verastem Inc. (VSTM) Buy with a $18 price target, as of its latest action on Feb 4, 2026. It has published 3 rating actions on VSTM since July 2021, including 0 upgrades and 0 downgrades.

Current rating
Buy
Price target
$18
Median target, all firms
Too few
Actions on VSTM
3

H.C. Wainwright price target on VSTM

$18$12$520222023202420252026
H.C. Wainwright price target on VSTM, each point a stated target, July 2021 to February 2026.

Every H.C. Wainwright rating on VSTM

How other firms rate VSTM

Each firm's latest rating and stated target in the last 12 months.

FirmRatingPrice targetDate
Wolfe ResearchOutperformSep 17, 2026
BTIGBuy$19Mar 12, 2026
H.C. WainwrightBuy$18Feb 4, 2026

Questions about H.C. Wainwright and VSTM

What is H.C. Wainwright's price target for VSTM?
H.C. Wainwright's latest stated price target for Verastem Inc. (VSTM) is $18, from its action on Feb 4, 2026.
What is H.C. Wainwright's rating on VSTM?
H.C. Wainwright rates VSTM Buy, a bullish rating, as of Feb 4, 2026.
When did H.C. Wainwright last change its view on VSTM?
On Feb 4, 2026, H.C. Wainwright starts coverage at Buy, price target $18.

More VSTM rating histories

All H.C. Wainwright ratingsVSTM news and filingsEvery analyst firm

From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.